🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Eligible participants with newly diagnosed myeloma who are not considered e...
Status
Recruiting
Location
Gundersen Lutheran
Start Date
2026-09
Trial ID
NCT07285239
This trial will study how safely the tazemetostat works with other therapie...
Status
Withdrawn
Location
California Cancer Associates For Research And Excellence, cCARE
Start Date
2021-12-22
Trial ID
NCT05205252
TAK-981 is being tested in combination with anti-CD38 monoclonal antibodies...
Status
Terminated
Location
Mayo Clinic Arizona - PPDS
Start Date
2021-04-20
Trial ID
NCT04776018
Treatments Being Tested
The primary objective of this study is to determine whether treatment with ...
Status
Completed
Location
Arizona Oncology Associates, PC - HAL
Start Date
2017-11-07
Trial ID
NCT03301220
Treatments Being Tested
This phase III trial compares the combination of four drugs (daratumumab, b...
Status
Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2021-02-24
Trial ID
NCT04566328
The purpose of this clinical trial is to (1) learn whether the BCMA-CD3 bis...
Status
Recruiting
Location
Clovis Community Medical Center
Start Date
2021-10-04
Trial ID
NCT05020236
Treatments Being Tested
This study is being done to answer the following question: Can the additio...
Status
Active Not Recruiting
Location
Alaska Oncology and Hematology LLC
Start Date
2025-08-11
Trial ID
NCT07085728
Treatments Being Tested
Background: Primary effusion lymphoma (PEL), plasmablastic lymphoma (PBL),...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2024-07-10
Trial ID
NCT05907759
Treatments Being Tested
This phase II trial compares the effect of the combination of daratumumab-h...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-26
Trial ID
NCT06948084